KLK3 and posterior cortical atrophy: Thus, our PSA-Gi may be a promising pre-operative prognostic biomarker predicting Pbx GG 3 tumors and ope GG ≥ 3 tumors, particularly in very low-risk PCa patients who have met PRIAS criteria and PCa patients at an intermediate risk.